Overview of Genetic Disorders

Genetic disorders are diseases that result from abnormalities in genes or chromosomes. These abnormalities can be present at birth or acquired later in life due to various factors. Genetic disorders can affect various aspects of an individual’s growth, development, morphology, metabolism, immune system, nervous system, and more. The incidence and severity of genetic disorders vary depending on the type of disease, the mode of inheritance, environmental factors, and other factors. The diagnosis and treatment of genetic disorders require the integration of knowledge and techniques from multiple disciplines, such as molecular biology, cytogenetics, biochemistry, clinical medicine, and others. Genes are composed of DNA (deoxyribonucleic acid), which contains instructions for cell function and individual characteristics. Genes usually exist in pairs of chromosomes within each cell, with one gene from each parent in each pair. Genes sometimes undergo changes, called mutations (or pathogenic variants), which may alter the function or expression of genes. Gene mutations can be inherited or acquired. Inherited mutations are those passed down from parents, while acquired mutations are those that occur during an individual’s lifetime, either randomly or due to environmental factors (such as cigarette smoke). Genetic disorders can be classified into five main types: chromosomal disorders, single gene disorders, mitochondrial disorders, multifactorial disorders, and hematopoietic disorders.

Chromosomal Disorders

Chromosomal disorders are diseases caused by abnormalities in the number or structure of chromosomes, which are the structures that hold genes or DNA within each cell. Humans normally have 23 pairs of chromosomes, one from each parent, but sometimes there are changes in the number or structure of chromosomes that can affect hundreds or thousands of genes and cause various health problems. There are two main types of chromosomal disorders: numerical abnormalities and structural abnormalities. Numerical abnormalities occur when there is a loss or gain of whole chromosomes, such as monosomy (one copy of a chromosome instead of two) or trisomy (three copies of a chromosome instead of two). Structural abnormalities occur when there are changes in the shape or arrangement of chromosomes, such as deletions (missing parts of a chromosome), duplications (extra parts of a chromosome), inversions (reversed segments of a chromosome), translocations (exchanged segments between non-homologous chromosomes), or rings (circular chromosomes). Chromosomal disorders can be inherited from parents or acquired during the formation of eggs or sperm (meiosis) or during the early development of the embryo (mitosis). The causes of chromosomal abnormalities are not fully understood, but they may be influenced by factors such as age, radiation, chemicals, viruses, or errors in DNA replication or repair. Chromosomal disorders can cause various physical and mental abnormalities, such as intellectual disability, congenital malformations, growth retardation, infertility, miscarriage, or cancer. Some examples of chromosomal disorders are Down syndrome (trisomy 21), Klinefelter syndrome (XXY), Turner syndrome (XO), Cri du chat syndrome (deletion 5p), and chronic myeloid leukemia (translocation 9;22). Various techniques can be used to diagnose chromosomal disorders by analyzing the number and structure of chromosomes in blood cells, bone marrow cells, amniotic fluid cells, or other tissues. These techniques include karyotyping, fluorescence in situ hybridization (FISH), microarray comparative genomic hybridization (aCGH), and next-generation sequencing (NGS). Chromosomal disorders cannot be cured, but they can be managed by symptomatic and supportive treatments, such as hormone replacement therapy, surgery, physical therapy, psychological counseling, special education, or gene therapy. The prognosis and life expectancy of people with chromosomal disorders depend on the type and severity of the disorder and the availability of medical care.

Single Gene Disorders

Single gene disorders are genetic diseases that are caused by changes or mutations in a single gene. They often have predictable inheritance patterns, such as dominant, recessive, or X-linked. There are over 10,000 known single gene disorders, affecting about one percent of the population. Some examples of single gene disorders are cystic fibrosis, hemochromatosis, Tay-Sachs disease, sickle cell anemia, Huntington's disease, and fragile X syndrome. These disorders can vary in their severity and symptoms depending on the type and location of the mutation, the function of the gene, and the influence of other genes and environmental factors. Some single gene disorders can be diagnosed at birth or in early childhood, while others may not appear until later in life. Single gene disorders can be treated in different ways, depending on the nature and extent of the disease. Some treatments aim to reduce or manage the symptoms, such as medications, dietary modifications, or physical therapy. Other treatments target the underlying cause of the disease, such as gene therapy, enzyme replacement therapy, or stem cell transplantation. However, many single gene disorders have no effective treatments or cures available yet. Genetic testing can help identify people who have or carry a single gene disorder or who are at risk of passing it on to their children. Genetic counseling can provide information and support to people who are affected by or concerned about a single gene disorder. Genetic research can also help discover new genes and mutations that cause single gene disorders and develop new ways to prevent, diagnose, and treat them.

Mitochondrial Disorders

Mitochondrial disorders are a group of diseases that affect the mitochondria, which are the tiny structures inside our cells that produce energy for the body. Mitochondria have their own DNA, which can be inherited from the mother or both parents, depending on the type of disorder. Mitochondrial disorders can cause a variety of symptoms and affect different organs, such as the brain, muscles, heart, liver, eyes, and ears. Some common examples of mitochondrial disorders are: mitochondrial myopathy, which causes muscle weakness and fatigue; Leber's hereditary optic neuropathy, which causes vision disorder in young adults; Leigh syndrome, which causes severe neurological problems in infants and children; MELAS syndrome, which causes stroke-like episodes and lactic acidosis; and MERRF syndrome, which causes myoclonic epilepsy and dementia. Mitochondrial disorders are diagnosed by a combination of clinical features, laboratory tests, genetic tests, and sometimes muscle or other tissue biopsies. There is no cure for mitochondrial disorders, but treatments may include medications, supplements, dietary changes, physical therapy, and supportive care. The prognosis of mitochondrial disorders depends on the type and severity of the disease and varies from person to person.

Multifactorial Disorders

Multifactorial disorders are conditions that are caused by multiple factors, such as genetic, lifestyle, and environmental factors. They are also called complex or polygenic disorders because they involve multiple genes that interact with each other and with external influences. Some examples of multifactorial disorders are heart disorders, type 2 diabetes, obesity, schizophrenia, asthma, depression, high blood pressure, Alzheimer’s disease, cancer, and birth defects. These disorders often run in families, but they do not have a clear pattern of inheritance because they depend on many factors that vary from person to person. Researchers are trying to identify the major genes and environmental factors that contribute to multifactorial disorders. This is challenging because each factor may have a small effect on the risk of developing the disorder, and different factors may interact in complex ways. However, understanding the causes of multifactorial disorders may help to prevent, diagnose, and treat them more effectively. Multifactorial disorders are very common and affect millions of people worldwide. They are influenced by many aspects of human biology and behavior, as well as by the surrounding environment. Therefore, preventing and managing these disorders requires a holistic approach that considers both genetic and non-genetic factors.

Hematopoietic Disorders

Hematopoietic disorders are conditions that affect the production or function of blood cells and platelets, which are made in the bone marrow by a process called hematopoiesis. These disorders can be inherited or acquired, and they can be benign or malignant. For example, Anemia, which causes low red blood cells or hemoglobin, can cause fatigue, weakness, shortness of breath, and pale skin. There are many types and causes of anemia, such as iron deficiency, vitamin B12 deficiency, hemolysis (destruction of red blood cells), and bone marrow failure. Thrombocytopenia causes low platelets and bleeding problems. Platelets are cell fragments that help the blood to clot and prevent bleeding. Thrombocytopenia can cause easy bruising, bleeding gums, nosebleeds, and heavy menstrual periods. Thrombocytopenia can be caused by immune disorders, infections, medications, or bone marrow diseases. Leukemia, lymphoma, and myeloma are cancers of different types of white blood cells. White blood cells are part of the immune system and help fight infections. These cancers cause abnormal white blood cells to multiply uncontrollably and crowd out normal blood cells in the bone marrow and blood. They can cause fever, infections, bleeding, anemia, and swollen lymph nodes. There are different types of leukemia based on the type and maturity of the white blood cells involved. Hematopoietic disorders can have various symptoms and complications, depending on the type and severity of the condition. They require different treatments depending on the underlying cause and the patient’s condition. More specifically, blood transfusions can help treat anemia, thrombocytopenia, bleeding disorders, and sickle cell disease. Drugs that can help treat or prevent symptoms or complications of hematopoietic disorders. Moreover, the replacement of diseased or damaged bone marrow with healthy bone marrow from a donor. Bone marrow transplantation can cure some hematopoietic disorders by providing a new source of blood cells. However, it is a complex and risky procedure that requires a compatible donor and intensive care before and after the transplant. In addition, the use of stem cells to generate new blood cells or repair damaged tissues. Stem cells are immature cells that can develop into different types of cells in the body. Stem cell therapy is an experimental treatment that aims to restore normal hematopoiesis by using stem cells from various sources such as umbilical cord blood, embryonic stem cells, or induced pluripotent stem cells.

References

  1. Wright CF, et al. Paediatric genomics: diagnosing rare disease in children. Nat Rev Genet. 2018;19(5):253-268.
  2. Antonarakis SE, et al. Mendelian disorders deserve more attention. Nat Rev Genet. 2006;7(4):277-282.
  3. Bamshad MJ, et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet. 2011;12(11):745-755.
  4. Boycott KM, et al. International cooperation to enable the diagnosis of all rare genetic diseases. Am J Hum Genet. 2017;100(5):695-705.
  5. Chong JX, et al. The genetic basis of Mendelian phenotypes: discoveries, challenges, and opportunities. Am J Hum Genet. 2015;97(2):199-215.
  6. Cooper DN, et al. Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease. Hum Genet. 2013;132(10):1077-1130.
  7. DeBoy EJ, et al. Familial clonal hematopoiesis in a long telomere syndrome kindred with germline POT1 variants and somatic mutations in multiple genes including TP53 and DNMT3A. N Engl J Med 2023;388(18):1701-1710.
  8. Gaulton KJ, et al. Interpreting non-coding disease-associated human variants using single-cell epigenomics. Nat Rev Genet 2023;24(5):315-330.
  9. Haerinck J, et al. The epithelial–mesenchymal plasticity landscape: principles of design and mechanisms of regulation. Nat Rev Genet 2023;24(5):331-347.
  10. Hook PW, et al. Beyond assembly: the increasing flexibility of single-molecule sequencing technology. Nat Rev Genet 2023;24(5):298-314.
  11. Petit C, et al. Deafness: from genetic architecture to gene therapy. Nat Rev Genet 2023;24(5):348-365.
  12. Selleri L, et al. Shaping faces: genetic and epigenetic control of craniofacial morphogenesis. Nat Rev Genet 2023;24(5):366-385.
  13. Wright CF, et al. Paediatric genomics: diagnosing rare disease in children. Nat Rev Genet 2018;19(5):253-268.
  14. Yozawitz E. Neonatal seizures. N Engl J Med 2023;388(18):1692-1700.
  15. Zoghbi HY, et al. Human molecular genetics and genomics — important advances and exciting possibilities. N Engl J Med 2021;384(1):1-4.
For research use only. Not intended for any clinical use.